From the introduction of new diagnosing technique Gene Xpert , diagnosing & treating TB has been a lot easier. So Nepal Govt. has adapted few changes in past t/t. This slide consists of slides on new case as well as MDR t/t.
Dr. Immanuel Joshua outlines key priorities and goals for ending tuberculosis (TB) globally and in India by 2025. The goals include reducing TB deaths and incidence rates by 90% and 80% respectively compared to 2015, and achieving zero catastrophic expenditures due to TB. Treatment duration and costs vary depending on whether TB is drug-sensitive or drug-resistant. India has committed to ending TB five years ahead of the global 2030 goal through its TB Free India campaign launched in 2018.
This document provides guidelines for tuberculosis management under the Revised National Tuberculosis Control Program (RNTCP) in India. It discusses Delhi's high TB incidence rate and key risk factors. It outlines diagnostic tools and algorithms for presumptive pulmonary, extra-pulmonary, pediatric, and drug-resistant TB. It also describes case definitions, classification by anatomical site and drug resistance, and drug sensitive TB treatment regimens. Key points covered include the national guidance on regimens, fixed-dose drug combinations, daily dosage schedules, managing treatment adherence through ICT-based monitoring, and pediatric dispersible formulations.
- The document summarizes plans for Measles Immunization Day and an MR (measles-rubella) vaccination campaign in India on March 16, 2019. It discusses measles and rubella diseases, the WHO goal to eliminate measles and control rubella by 2020, and details of the MR vaccine, including its benefits, administration, storage, adverse reactions and contraindications. The campaign aims to vaccinate over 95% of children aged 9 months to 15 years to boost population immunity against both diseases. Careful planning and coordination is underway between health departments and other stakeholders to make the campaign a success.
Pulmonary tuberculosis is caused by the bacterium Mycobacterium tuberculosis and is spread through inhaling droplets from an infected person when they cough, sneeze, or laugh. It is a chronic infection characterized by weight loss. Diagnosis involves chest x-rays, sputum tests, and the Mantoux tuberculin skin test. Treatment requires taking multiple antibiotics like isoniazid and rifampin daily for 6-12 months to prevent resistance. Complications can include infection of bones, brain, liver or kidneys if left untreated. Prevention involves proper ventilation, covering coughs, mask wearing, vaccination, and completing the full drug regimen.
This document provides treatment guidelines for tuberculosis. It outlines the aims of TB treatment as curing the patient, preventing death from active or relapsed TB, decreasing transmission, and preventing drug resistance. It describes the initial and continuation phases of treatment for new and previously treated cases. It also defines different types of TB cases and provides recommended drug regimens and dosages depending on the category of TB patient. Isoniazid, rifampicin, pyrazinamide, and ethambutol are first-line oral drugs, while streptomycin and thioacetazone are also mentioned. BCG vaccination guidelines are also briefly covered.
CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...Dr. Darayus P. Gazder
A 71-year-old male presented with 2 months of fever, headaches, and weight loss. Initial workup revealed anemia, elevated liver enzymes and inflammatory markers. He was treated for enteric fever but did not improve. Further testing showed pancytopenia, a weakly positive ANA, and a bone marrow biopsy suggestive of granulomas. He developed cough and hypoxemia. Imaging found pleural effusions and lung consolidation. The working diagnosis shifted to tuberculosis given suggestive bone marrow findings. Treatment with antitubercular therapy and steroids was started.
This document provides an overview of the approach to cough in children. It begins with background on cough and the cough reflex pathway. It then discusses classifications of cough based on duration, quality, and etiology. The document outlines the important components of history taking and physical examination for a child with cough. It recommends investigations such as chest X-ray, pulmonary function tests, and bronchoscopy if needed. The document concludes with guidelines for managing cough in children based on its underlying cause.
This document discusses shortness of breath (dyspnoea), including its definition, grading scales, common causes, history taking, physical examination findings, differential diagnosis, initial investigations, and basic management. It defines dyspnoea as an uncomfortable sensation of breathing that feels inappropriate or disproportionate. Grading scales like the MRC and NYHA are described. Common causes involve the cardiovascular, respiratory, and other body systems. A thorough history and physical exam are important for determining the underlying etiology. Initial tests may include pulse oximetry, peak flow measurement, chest x-ray, ECG, and lung biopsy. Treatment is aimed at addressing the specific cause, and may involve pharmacological therapies, oxygen supplementation, or non-
Dr. Immanuel Joshua outlines key priorities and goals for ending tuberculosis (TB) globally and in India by 2025. The goals include reducing TB deaths and incidence rates by 90% and 80% respectively compared to 2015, and achieving zero catastrophic expenditures due to TB. Treatment duration and costs vary depending on whether TB is drug-sensitive or drug-resistant. India has committed to ending TB five years ahead of the global 2030 goal through its TB Free India campaign launched in 2018.
This document provides guidelines for tuberculosis management under the Revised National Tuberculosis Control Program (RNTCP) in India. It discusses Delhi's high TB incidence rate and key risk factors. It outlines diagnostic tools and algorithms for presumptive pulmonary, extra-pulmonary, pediatric, and drug-resistant TB. It also describes case definitions, classification by anatomical site and drug resistance, and drug sensitive TB treatment regimens. Key points covered include the national guidance on regimens, fixed-dose drug combinations, daily dosage schedules, managing treatment adherence through ICT-based monitoring, and pediatric dispersible formulations.
- The document summarizes plans for Measles Immunization Day and an MR (measles-rubella) vaccination campaign in India on March 16, 2019. It discusses measles and rubella diseases, the WHO goal to eliminate measles and control rubella by 2020, and details of the MR vaccine, including its benefits, administration, storage, adverse reactions and contraindications. The campaign aims to vaccinate over 95% of children aged 9 months to 15 years to boost population immunity against both diseases. Careful planning and coordination is underway between health departments and other stakeholders to make the campaign a success.
Pulmonary tuberculosis is caused by the bacterium Mycobacterium tuberculosis and is spread through inhaling droplets from an infected person when they cough, sneeze, or laugh. It is a chronic infection characterized by weight loss. Diagnosis involves chest x-rays, sputum tests, and the Mantoux tuberculin skin test. Treatment requires taking multiple antibiotics like isoniazid and rifampin daily for 6-12 months to prevent resistance. Complications can include infection of bones, brain, liver or kidneys if left untreated. Prevention involves proper ventilation, covering coughs, mask wearing, vaccination, and completing the full drug regimen.
This document provides treatment guidelines for tuberculosis. It outlines the aims of TB treatment as curing the patient, preventing death from active or relapsed TB, decreasing transmission, and preventing drug resistance. It describes the initial and continuation phases of treatment for new and previously treated cases. It also defines different types of TB cases and provides recommended drug regimens and dosages depending on the category of TB patient. Isoniazid, rifampicin, pyrazinamide, and ethambutol are first-line oral drugs, while streptomycin and thioacetazone are also mentioned. BCG vaccination guidelines are also briefly covered.
CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...Dr. Darayus P. Gazder
A 71-year-old male presented with 2 months of fever, headaches, and weight loss. Initial workup revealed anemia, elevated liver enzymes and inflammatory markers. He was treated for enteric fever but did not improve. Further testing showed pancytopenia, a weakly positive ANA, and a bone marrow biopsy suggestive of granulomas. He developed cough and hypoxemia. Imaging found pleural effusions and lung consolidation. The working diagnosis shifted to tuberculosis given suggestive bone marrow findings. Treatment with antitubercular therapy and steroids was started.
This document provides an overview of the approach to cough in children. It begins with background on cough and the cough reflex pathway. It then discusses classifications of cough based on duration, quality, and etiology. The document outlines the important components of history taking and physical examination for a child with cough. It recommends investigations such as chest X-ray, pulmonary function tests, and bronchoscopy if needed. The document concludes with guidelines for managing cough in children based on its underlying cause.
This document discusses shortness of breath (dyspnoea), including its definition, grading scales, common causes, history taking, physical examination findings, differential diagnosis, initial investigations, and basic management. It defines dyspnoea as an uncomfortable sensation of breathing that feels inappropriate or disproportionate. Grading scales like the MRC and NYHA are described. Common causes involve the cardiovascular, respiratory, and other body systems. A thorough history and physical exam are important for determining the underlying etiology. Initial tests may include pulse oximetry, peak flow measurement, chest x-ray, ECG, and lung biopsy. Treatment is aimed at addressing the specific cause, and may involve pharmacological therapies, oxygen supplementation, or non-
Tuberculosis is caused by Mycobacterium tuberculosis and is a chronic infectious disease characterized by vague symptoms and a protracted course. India accounts for one third of the global TB burden, with 15 million infected people in India and 3-4 million of those being children. Tuberculosis most commonly enters the body through inhalation and can spread through droplets or ingestion. Primary infection typically occurs in the lungs or lymph nodes and may heal or progress to more serious complications affecting multiple organs if not contained. Common symptoms in children include failure to thrive, fever, and painless lymphadenopathy.
This document provides an overview of the management of drug-resistant tuberculosis (DR-TB). It defines different types of DR-TB including mono-resistant TB, poly-resistant TB, multidrug-resistant TB (MDR-TB), and extensively drug-resistant TB (XDR-TB). It discusses the epidemiology, mechanisms of drug resistance, clinical features, diagnosis, and treatment regimens for MDR-TB and XDR-TB according to WHO guidelines. The treatment regimens involve the use of second-line drugs including fluoroquinolones, aminoglycosides, ethionamide, cycloserine, linezolid, and others. Strict adherence to treatment is important to prevent the development
The document provides an overview of updates to India's National Tuberculosis Elimination Programme (NTEP) guidelines in 2020. It summarizes the history of tuberculosis programs in India since 1997 and key changes introduced in 2020, including renaming the program from the Revised National Tuberculosis Control Programme to NTEP. It outlines case definitions, diagnostic algorithms, treatment guidelines for drug-sensitive and drug-resistant tuberculosis, and definitions of treatment outcomes. The guidelines emphasize making every attempt to microbiologically confirm TB diagnoses and introduce changes like daily drug dosing and expanding the use of molecular diagnostic tests like CBNAAT.
This document discusses the various complications that can arise from tuberculosis (TB). It outlines local complications affecting the lungs including tuberculomas, cavities, scarring, bronchiectasis, and aspergillomas. It also discusses airway complications such as stenosis. Vascular issues like hemoptysis are reviewed. Mediastinal complications including lymphadenitis and fistulas are summarized. Pleural issues such as empyema and pneumothorax are covered. Finally, chest wall TB and spondylitis are mentioned as extrathoracic complications. Recognition of these sequelae is important for diagnosis and treatment of TB.
Diagnosis & management of status asthmaticusSheela Aglecha
This document provides guidance on diagnosing and managing status asthmaticus and acute severe asthma exacerbations in children. Key points include:
1. Status asthmaticus is acute severe asthma that fails to respond to conventional therapy like inhaled beta-agonists and oral steroids.
2. Management involves 3 pillars - oxygen, nebulized beta-agonists like salbutamol, and steroids like intravenous hydrocortisone.
3. If the child does not improve with initial treatments, additional therapies may be needed like subcutaneous or intravenous beta-agonists, magnesium sulfate, or aminophylline. Mechanical ventilation could be required if the child does not respond to medical management
This document outlines the various diagnostic tests, guidelines, and treatment approaches for pneumonia. It discusses sputum microscopy and culture, as well as tests for bacteria, fungi, viruses, and other pathogens. Guidelines are provided for empiric antibiotic therapy for community-acquired pneumonia based on severity and risk factors. Diagnostic testing and treatment approaches are also described for healthcare-associated pneumonia and specific organisms like Pseudomonas and Legionella. The document emphasizes the importance of supportive care and preventing pneumonia through vaccination and infection control practices.
This document describes several neonatal reflexes present in newborn infants, including Moro's reflex, the palmar grasp, tonic neck reflex, rooting reflex, and sucking reflex. These reflexes are unconditioned responses to specific stimuli and help assess neurodevelopment. The document provides details on what elicits each reflex, the typical response, when they appear and disappear during development, and potential abnormalities if a reflex is absent, exaggerated, or persists beyond the normal timeframe. Understanding neonatal reflexes is important for evaluating infant development and identifying possible neurodevelopmental issues.
The document discusses India's National Tuberculosis Elimination Program (NTEP), formerly known as the Revised National Tuberculosis Control Programme (RNTCP). It outlines the evolution and key components of NTEP, including the adoption of the DOTS strategy, STOP TB and End TB strategies, and the current National Strategic Plan 2017-2025. The summary highlights that NTEP aims to eliminate TB in India by 2025, utilizing active case finding, newer treatment regimens, private sector engagement, and IT-enabled surveillance and support for TB patients.
This document discusses the goals and management of asthma. The goals of asthma management are to achieve symptom control, prevent exacerbations, maintain normal pulmonary function, avoid adverse medication effects, and prevent mortality. Management involves both pharmacological and non-pharmacological approaches. Pharmacological management follows a stepwise treatment approach based on a scoring system, starting with reliever medication and increasing treatment up to six steps as needed to achieve symptom control.
India is the highest TB burden country in the world & accounts for nearly 1/5th (20 per cent) of global burden of tuberculosis, 2/3rd of cases in SEAR. Every year approximately 1.8 million persons develop tuberculosis, of which about 0.8 million are new smear positive highly'- infectious cases.Annual risk of becoming infected with TB is 1.5 % and once infected there is 10 % life-time risk of developing TB disease
Clubbing, also known as Hippocratic fingers, is a thickening of tissues at the base of fingernails and toenails such that the normal angle between the nail and digit is filled in. It is caused by increased levels of vascular endothelial growth factor (VEGF) which induces vascular changes and tissue proliferation in the nails. Common causes include lung diseases like bronchitis and cancer, as well as non-lung conditions such as liver cirrhosis. Clubbing can range from nail bed fluctuation to severe bony changes and is classified in grades based on physical appearance.
Febrile seizures are common in young children under 6 years old, occurring in 2-4% of children. They are convulsions associated with a fever over 38°C without an infection of the brain or metabolic abnormality. Febrile seizures are categorized as simple or complex based on duration and features. Treatment involves antipyretics to reduce fever along with anticonvulsants if seizures last more than 5 minutes. While concerning for parents, febrile seizures are generally benign and do not require long-term anticonvulsant treatment in otherwise healthy children with simple febrile seizures.
This slides helps to know the history of Immunisation along with the present programs & conditions. This also consists of Immunisation Schedule of Nepal along with features of some vaccines.
Tabindah is a 3 1/2 year old girl from a rural area in Kashmir who presents with diarrhea. She has been experiencing 5-6 loose stools per day along with abdominal pain and nausea. Her diet is deficient in calories, protein, fat, iron and calcium compared to her requirements. On examination, she has no signs of dehydration. She was diagnosed with non-dehydrating diarrhea and prescribed ORS, zinc and a probiotic.
This document presents a case study of a 21-year-old male patient diagnosed with tuberculoid leprosy. It includes details of the patient's history, complaints, physical examination, investigations, and proposed treatment. The patient presented with a reddish patch and numbness on his right leg for 4 months. On examination, he had a well-defined erythematous skin patch on his right leg with decreased sensation. Skin biopsy revealed tuberculoid leprosy. He was started on multidrug therapy consisting of rifampicin and dapsone for 6 months to treat his paucibacillary leprosy.
This document discusses three cases of tuberculosis (TB). The first case involves a 52-year-old Hispanic female presenting with cough, sputum, fatigue, and blood in her sputum. Examination finds lymph nodes and rales in her left lung. Tests show a positive PPD test and cavitary lesions on her chest X-ray, confirming active pulmonary TB. The second case is about a man referred for cough and fever, with bilateral pneumonia and apical involvement on chest X-ray. Sputum smear confirms acid-fast bacilli, and TB is diagnosed. He refuses admission and treatment. The third case discusses a woman diagnosed with sputum smear-negative pulmonary TB who stops treatment and attending follow
Febrile seizure / Pediatrics
Simple vs. Complex seizure
Possible explanation of febrile seizure
Risk Factors for Febrile Seizures
Risk Factors for Recurrence of Febrile Seizure
Risk Factors for Occurrence of Subsequent Epilepsy After a Febrile Seizure
Genetic Factors
Evaluation
Lumbar Puncture
Optional LP
Electroencephalogram
Blood Studies
Neuroimaging
TREATMENT
The document discusses recent advances in the treatment of tuberculosis (TB) and multi-drug resistant TB (MDR-TB) in India. It outlines the standard first-line and MDR-TB treatment regimens used in the country, including the introduction of a shorter 9-11 month regimen for MDR-TB. It also discusses the use of newer drugs like bedaquiline and delamanid to treat more resistant forms of TB. Additionally, it covers improvements to infection control practices in healthcare facilities to help eliminate TB transmission.
This presentation intends to throw light on the Tuberculosis burden of our country with the prime focus on the rapid emergence of drug resistant TB.Along with it,the recent RNTCP guidelines for case detection,early diagnosis and complete pharmacotherapy and treatment duration of different cases of tuberculosis.
Tuberculosis is caused by Mycobacterium tuberculosis and is a chronic infectious disease characterized by vague symptoms and a protracted course. India accounts for one third of the global TB burden, with 15 million infected people in India and 3-4 million of those being children. Tuberculosis most commonly enters the body through inhalation and can spread through droplets or ingestion. Primary infection typically occurs in the lungs or lymph nodes and may heal or progress to more serious complications affecting multiple organs if not contained. Common symptoms in children include failure to thrive, fever, and painless lymphadenopathy.
This document provides an overview of the management of drug-resistant tuberculosis (DR-TB). It defines different types of DR-TB including mono-resistant TB, poly-resistant TB, multidrug-resistant TB (MDR-TB), and extensively drug-resistant TB (XDR-TB). It discusses the epidemiology, mechanisms of drug resistance, clinical features, diagnosis, and treatment regimens for MDR-TB and XDR-TB according to WHO guidelines. The treatment regimens involve the use of second-line drugs including fluoroquinolones, aminoglycosides, ethionamide, cycloserine, linezolid, and others. Strict adherence to treatment is important to prevent the development
The document provides an overview of updates to India's National Tuberculosis Elimination Programme (NTEP) guidelines in 2020. It summarizes the history of tuberculosis programs in India since 1997 and key changes introduced in 2020, including renaming the program from the Revised National Tuberculosis Control Programme to NTEP. It outlines case definitions, diagnostic algorithms, treatment guidelines for drug-sensitive and drug-resistant tuberculosis, and definitions of treatment outcomes. The guidelines emphasize making every attempt to microbiologically confirm TB diagnoses and introduce changes like daily drug dosing and expanding the use of molecular diagnostic tests like CBNAAT.
This document discusses the various complications that can arise from tuberculosis (TB). It outlines local complications affecting the lungs including tuberculomas, cavities, scarring, bronchiectasis, and aspergillomas. It also discusses airway complications such as stenosis. Vascular issues like hemoptysis are reviewed. Mediastinal complications including lymphadenitis and fistulas are summarized. Pleural issues such as empyema and pneumothorax are covered. Finally, chest wall TB and spondylitis are mentioned as extrathoracic complications. Recognition of these sequelae is important for diagnosis and treatment of TB.
Diagnosis & management of status asthmaticusSheela Aglecha
This document provides guidance on diagnosing and managing status asthmaticus and acute severe asthma exacerbations in children. Key points include:
1. Status asthmaticus is acute severe asthma that fails to respond to conventional therapy like inhaled beta-agonists and oral steroids.
2. Management involves 3 pillars - oxygen, nebulized beta-agonists like salbutamol, and steroids like intravenous hydrocortisone.
3. If the child does not improve with initial treatments, additional therapies may be needed like subcutaneous or intravenous beta-agonists, magnesium sulfate, or aminophylline. Mechanical ventilation could be required if the child does not respond to medical management
This document outlines the various diagnostic tests, guidelines, and treatment approaches for pneumonia. It discusses sputum microscopy and culture, as well as tests for bacteria, fungi, viruses, and other pathogens. Guidelines are provided for empiric antibiotic therapy for community-acquired pneumonia based on severity and risk factors. Diagnostic testing and treatment approaches are also described for healthcare-associated pneumonia and specific organisms like Pseudomonas and Legionella. The document emphasizes the importance of supportive care and preventing pneumonia through vaccination and infection control practices.
This document describes several neonatal reflexes present in newborn infants, including Moro's reflex, the palmar grasp, tonic neck reflex, rooting reflex, and sucking reflex. These reflexes are unconditioned responses to specific stimuli and help assess neurodevelopment. The document provides details on what elicits each reflex, the typical response, when they appear and disappear during development, and potential abnormalities if a reflex is absent, exaggerated, or persists beyond the normal timeframe. Understanding neonatal reflexes is important for evaluating infant development and identifying possible neurodevelopmental issues.
The document discusses India's National Tuberculosis Elimination Program (NTEP), formerly known as the Revised National Tuberculosis Control Programme (RNTCP). It outlines the evolution and key components of NTEP, including the adoption of the DOTS strategy, STOP TB and End TB strategies, and the current National Strategic Plan 2017-2025. The summary highlights that NTEP aims to eliminate TB in India by 2025, utilizing active case finding, newer treatment regimens, private sector engagement, and IT-enabled surveillance and support for TB patients.
This document discusses the goals and management of asthma. The goals of asthma management are to achieve symptom control, prevent exacerbations, maintain normal pulmonary function, avoid adverse medication effects, and prevent mortality. Management involves both pharmacological and non-pharmacological approaches. Pharmacological management follows a stepwise treatment approach based on a scoring system, starting with reliever medication and increasing treatment up to six steps as needed to achieve symptom control.
India is the highest TB burden country in the world & accounts for nearly 1/5th (20 per cent) of global burden of tuberculosis, 2/3rd of cases in SEAR. Every year approximately 1.8 million persons develop tuberculosis, of which about 0.8 million are new smear positive highly'- infectious cases.Annual risk of becoming infected with TB is 1.5 % and once infected there is 10 % life-time risk of developing TB disease
Clubbing, also known as Hippocratic fingers, is a thickening of tissues at the base of fingernails and toenails such that the normal angle between the nail and digit is filled in. It is caused by increased levels of vascular endothelial growth factor (VEGF) which induces vascular changes and tissue proliferation in the nails. Common causes include lung diseases like bronchitis and cancer, as well as non-lung conditions such as liver cirrhosis. Clubbing can range from nail bed fluctuation to severe bony changes and is classified in grades based on physical appearance.
Febrile seizures are common in young children under 6 years old, occurring in 2-4% of children. They are convulsions associated with a fever over 38°C without an infection of the brain or metabolic abnormality. Febrile seizures are categorized as simple or complex based on duration and features. Treatment involves antipyretics to reduce fever along with anticonvulsants if seizures last more than 5 minutes. While concerning for parents, febrile seizures are generally benign and do not require long-term anticonvulsant treatment in otherwise healthy children with simple febrile seizures.
This slides helps to know the history of Immunisation along with the present programs & conditions. This also consists of Immunisation Schedule of Nepal along with features of some vaccines.
Tabindah is a 3 1/2 year old girl from a rural area in Kashmir who presents with diarrhea. She has been experiencing 5-6 loose stools per day along with abdominal pain and nausea. Her diet is deficient in calories, protein, fat, iron and calcium compared to her requirements. On examination, she has no signs of dehydration. She was diagnosed with non-dehydrating diarrhea and prescribed ORS, zinc and a probiotic.
This document presents a case study of a 21-year-old male patient diagnosed with tuberculoid leprosy. It includes details of the patient's history, complaints, physical examination, investigations, and proposed treatment. The patient presented with a reddish patch and numbness on his right leg for 4 months. On examination, he had a well-defined erythematous skin patch on his right leg with decreased sensation. Skin biopsy revealed tuberculoid leprosy. He was started on multidrug therapy consisting of rifampicin and dapsone for 6 months to treat his paucibacillary leprosy.
This document discusses three cases of tuberculosis (TB). The first case involves a 52-year-old Hispanic female presenting with cough, sputum, fatigue, and blood in her sputum. Examination finds lymph nodes and rales in her left lung. Tests show a positive PPD test and cavitary lesions on her chest X-ray, confirming active pulmonary TB. The second case is about a man referred for cough and fever, with bilateral pneumonia and apical involvement on chest X-ray. Sputum smear confirms acid-fast bacilli, and TB is diagnosed. He refuses admission and treatment. The third case discusses a woman diagnosed with sputum smear-negative pulmonary TB who stops treatment and attending follow
Febrile seizure / Pediatrics
Simple vs. Complex seizure
Possible explanation of febrile seizure
Risk Factors for Febrile Seizures
Risk Factors for Recurrence of Febrile Seizure
Risk Factors for Occurrence of Subsequent Epilepsy After a Febrile Seizure
Genetic Factors
Evaluation
Lumbar Puncture
Optional LP
Electroencephalogram
Blood Studies
Neuroimaging
TREATMENT
The document discusses recent advances in the treatment of tuberculosis (TB) and multi-drug resistant TB (MDR-TB) in India. It outlines the standard first-line and MDR-TB treatment regimens used in the country, including the introduction of a shorter 9-11 month regimen for MDR-TB. It also discusses the use of newer drugs like bedaquiline and delamanid to treat more resistant forms of TB. Additionally, it covers improvements to infection control practices in healthcare facilities to help eliminate TB transmission.
This presentation intends to throw light on the Tuberculosis burden of our country with the prime focus on the rapid emergence of drug resistant TB.Along with it,the recent RNTCP guidelines for case detection,early diagnosis and complete pharmacotherapy and treatment duration of different cases of tuberculosis.
This document discusses the management of multidrug-resistant tuberculosis (MDR-TB) and the roles of pharmacists. It provides an overview of TB, defines various types of drug resistance, and reviews the epidemiology and standardized treatment regimen for MDR-TB. The roles of pharmacists in MDR-TB management include treatment monitoring to improve adherence, monitoring patient weight and side effects, and providing counseling to support treatment completion. Studies show better treatment outcomes when pharmacists are involved in TB patient care and management.
Diagnosis and management of tuberculosis with revised rntcpDrPrincePrakash
The document provides guidelines for the diagnosis and management of tuberculosis (TB) according to the Revised National Tuberculosis Control Programme (RNTCP). It discusses definitions of TB cases, classification based on treatment history, diagnostic methods, treatment regimens for pulmonary and extra-pulmonary TB, management of drug-resistant TB, and follow-up procedures. Key changes in the recent guidelines include introducing a daily treatment regimen for both new and previously treated TB cases, as well as additional guidance for diagnosing and treating multi-drug resistant TB.
Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic of att. Tuberculosis and basic o
RNTCP in India has gone a lot of updates in the resent times. The recent updates in RNTCP in India have been summarised in this presentation. Management of Drug sensitive and Drug Resistant TB have been included in the presentation.
This document presents the case of a 26-year-old female patient who was admitted with a 5-month history of intermittent fever, weight loss, cough, and breathlessness. Her past medical history includes a previous episode of pulmonary tuberculosis that was treated. On examination, she had signs of respiratory involvement including reduced breath sounds and crackles on the right side. Investigations showed infiltrates on the right lung. She was started on treatment but did not improve. Further testing revealed she had inh resistant pulmonary tuberculosis. She was referred for specialized management and her diagnosis was confirmed as suspected MDR-TB.
This document outlines guidelines for tuberculosis treatment under India's Revised National Tuberculosis Control Programme (RNTCP) using a daily drug regimen rather than the previous thrice-weekly regimen. It describes the treatment protocols for new and previously treated TB cases, including drug combinations, dosages, treatment duration and monitoring. A key change is the use of fixed-dose combination drugs packaged for daily administration over 4 weeks. Strict treatment supervision and support is emphasized to ensure patient adherence and cure.
This document provides guidelines for the treatment of tuberculosis (TB). It discusses the causative bacteria of TB, types of TB infections, methods for diagnosing TB, treatment approaches, and special considerations for treating TB in high-risk groups like those with HIV/AIDS or liver disease. The treatment guidelines recommend a two-phase antibiotic regimen using a combination of first-line drugs over a period of 6-9 months depending on risk factors and response to treatment. Considerations for treating drug-resistant TB and managing TB in patients with renal or hepatic impairment are also covered.
The document provides information on tuberculosis (TB) in India, including:
1. Objectives of the National Strategic Plan for TB which include achieving high notification and treatment success rates as well as improving outcomes for drug resistant and HIV-associated TB cases.
2. Definitions related to TB including presumptive TB, drug resistant TB, new and previously treated cases, and treatment outcomes.
3. Guidelines for diagnosis and treatment of drug susceptible and drug resistant TB, including use of newer drugs and shorter regimens for MDR-TB.
4. Criteria for diagnosis of non-tuberculous mycobacterial lung disease.
B (PMDT) can be defined as “all associated functions related to providing services based in the TB strategy in order to achieve the targets set for drug-resistant TB in the Global Plan to Stop TB 2011–2015”
The document summarizes key changes between the 5th and 6th editions of Bangladesh's tuberculosis treatment guidelines. Some of the major changes include:
- The diagnostic criteria was changed from 3 weeks of cough to 2 weeks for requesting sputum testing.
- The classification of TB patients was modified to have new categories such as bacteriologically positive/negative PTB and clinically diagnosed PTB.
- The treatment duration for certain extrapulmonary TB cases such as TB meningitis was increased from 6 months to 12 months.
- For previously treated cases (Category 2), the recommended regimen was modified and new options for 6 or 12 month treatments were introduced, and levofloxacin was added as an oral substitute
This document provides information on multi-drug resistant tuberculosis (MDR-TB). It discusses the epidemiology and definitions of drug-resistant TB. It describes how to diagnose DR-TB through tests like Xpert MTB/RIF, line probe assay, and culture and drug susceptibility testing. Treatment options for DR-TB are also outlined, including shorter standardized treatment regimens and longer regimens. Criteria for determining appropriate treatment regimens and defining treatment outcomes are also summarized.
1. Tuberculosis remains a major global health problem, with an estimated 2 billion people infected and 10 million new active cases each year resulting in 1.5 million deaths.
2. Standard short course DOTS therapy involves a combination of drugs administered over 6-9 months depending on the category of TB. Adverse effects of the main anti-TB drugs are discussed.
3. Multidrug resistant TB and extensively drug resistant TB present significant treatment challenges, requiring prolonged courses of second-line drugs and close monitoring given their increased toxicity. Preventing further emergence of drug resistance is critical.
1. The document discusses the management of tuberculosis, including the history, statistics, principles of treatment, protocols, side effects of drugs, and the Revised National Tuberculosis Control Programme in India.
2. It covers topics like tuberculosis and diabetes, tuberculosis and HIV co-infection, multi-drug resistant tuberculosis, and paradoxical reactions seen with antituberculosis treatment and antiretroviral therapy.
3. Guidelines are provided for treatment of different categories of tuberculosis patients, management of drug interactions and adverse effects, and regimens for multi-drug resistant cases.
This document discusses the challenges of providing radiation oncology care during the COVID-19 pandemic. It outlines various cancer patient groups that are most vulnerable to COVID-19 and the difficulties this poses for cancer treatment. Recommendations are provided for prioritizing patients and potentially altering treatment approaches, such as using hypofractionated regimens, for different cancer types including breast, lung, head and neck, and gynecological cancers. Guidance emphasizes continuing curative treatments when possible while considering safety and minimizing risks of virus exposure and spread.
Updated Part -3 Management of TB.. DR. Kiran G. Piparva 2020 [Autosaved].pptxDrKGPiparvaPharmalec
The document discusses guidelines for treating tuberculosis (TB) according to the National Tuberculosis Elimination Programme (NTEP) in India. It outlines the goals of TB treatment, general principles of combination drug therapy, and categories of drug-sensitive and drug-resistant TB. It provides details on recommended drug regimens for different types of TB cases, including mono drug-resistant TB, rifampin-resistant or multidrug-resistant TB, and management of associated adverse drug reactions. It also covers TB treatment in special populations and preventive therapy for latent TB infection.
This document provides treatment guidelines for tuberculosis. It outlines the aims of TB treatment as curing the patient, preventing death from active or relapsed TB, decreasing transmission, and preventing drug resistance. It describes the initial and continuation phases of treatment for new and previously treated cases. It also defines different types of TB cases and provides recommended drug regimens and dosages depending on the category of TB patient. Isoniazid, rifampicin, pyrazinamide, and ethambutol are first-line oral drugs, while streptomycin and thioacetazone are also mentioned. BCG vaccination guidelines are also briefly covered.
The document discusses malnutrition, defining it as a cellular imbalance between nutrient supply and demand. It describes different types of malnutrition including protein energy malnutrition (PEM), marasmus caused by inadequate protein and calories, and kwashiorkor caused by inadequate protein intake. Diagnosis is based on weight for age, height for age, and weight for height measurements. Severe acute malnutrition is diagnosed using Z-scores below -3 or mid-upper arm circumference (MUAC) below 11.5 cm. Treatment involves ready-to-use therapeutic foods (RUTF) and managing medical complications.
The document provides information about the sclera, including its structure, thickness, apertures, nerve supply, inflammation conditions like episcleritis and scleritis, and other related topics. The sclera forms the posterior five-sixths of the outer fibrous tunic of the eyeball. It varies in thickness from 1mm posteriorly to 0.3mm at the muscle insertions. It contains three layers and is pierced by blood vessels and nerves. Inflammation of the sclera can cause episcleritis or scleritis, with the latter being a more serious condition sometimes associated with underlying systemic diseases.
The eyelids act as protective shutters for the eyes. They spread tears across the cornea and conjunctiva to keep the eyes moist. When closed, the eyelids also help drain tears via the lacrimal pump system. The eyelids are composed of several layers including skin, muscle fibers, and conjunctiva. Structures like the tarsal plates provide shape and firmness to the lids. Glands such as the meibomian glands secrete oils to form the outer layer of the tear film and prevent evaporation of tears. Contraction of the orbicularis muscle aids in eyelid closure and tear drainage.
chelating agents are very important regarding questions in toxicology in PG entrance exam, & its a confusing topic because there is controversy in selecting specific agents for particular poisoning. I hope this slide will be very useful.
This is just a short & simplified slide made easy for undergraduate level . Important things have been highlighted. Before classifying system,I felt that few terms have to be described, so I have put few extra slides in the beginning.
For this slide, i have done very hard work. This anatomy has been presented in a very simple way. The video of this slide is available on youtube as well. You can search with my name in utube. Thank u.
This slide includes general principles of fracture management. This is just a basic idea. I have tried to include figures as well as videos. But unfortunately videos wont play here.
This document provides an anatomy overview of the pharynx. It describes the structures and divisions of the pharynx including the soft palate, muscles of the soft palate, and the three parts of the pharynx - nasopharynx, oropharynx, and laryngopharynx. It discusses the walls, muscles, openings, lymphatic drainage and other anatomical features of each part of the pharynx in detail.
This document provides an anatomical overview of the external ear, which consists of the pinna, external acoustic canal, and tympanic membrane. It describes the structures and features of each component in detail. The pinna is made of elastic cartilage covered in skin. The external acoustic canal is 24mm long and S-shaped, with an outer cartilaginous portion and inner bony portion. The tympanic membrane separates the external canal from the middle ear and is angled obliquely, with a central umbo where the malleus attaches. Nerves, blood supply, and lymphatic drainage are also outlined for each structure.
Acute suppurative otitis media is an infection of the middle ear caused most commonly by Streptococcus pneumoniae or Hemophilus influenzae in children. It begins with blockage of the Eustachian tube by inflammation, followed by invasion of pathogens and exudation of fluid into the middle ear space. Signs include a retracted, bulging eardrum and conductive hearing loss. Treatment involves antibiotics to control the infection over 10 days as well as pain medications. Myringotomy may be needed to drain pus if symptoms are not improving. Complications can include persistent fluid, abscess, or spread to the mastoid bone.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
The simplified electron and muon model, Oscillating Spacetime: The Foundation...RitikBhardwaj56
Discover the Simplified Electron and Muon Model: A New Wave-Based Approach to Understanding Particles delves into a groundbreaking theory that presents electrons and muons as rotating soliton waves within oscillating spacetime. Geared towards students, researchers, and science buffs, this book breaks down complex ideas into simple explanations. It covers topics such as electron waves, temporal dynamics, and the implications of this model on particle physics. With clear illustrations and easy-to-follow explanations, readers will gain a new outlook on the universe's fundamental nature.
2. Type of TB Intensive Phase Continuation Phase
New TB Cases
All forms:
- Adult & childhood
- Bacteriological or clinically
diagnosed
- pulmonary or extra-pulmonary
2 HRZE 4HR
New TB (severe cases)
All forms:
E.g. CNS TB, Musculoskeletal TB,
Miliary TB
2HRZE 7 HRE with the possibility of 3
HRE in the end
8/13/2019 NISCHAL SHRESTHA 2
3. For all the retreatment cases
• Xpert MTB/Rif test or CB-NAAT (cartridge based nucleic acid
amplification test):
>detect bacilli and resistance to Rif , within 2 hours.
>This test is done to see the status of resistance to Rifampicin
followed by line probe assay (LPA) among those having MTB +ve and
Rifampicin sensitive for Isoniazid resistance status.
ATT drug that goes resistance fastest is Isonoazid.
8/13/2019 NISCHAL SHRESTHA 3
4. Xpert MTB/ Rif
Rifampicin sensitive
LPA- isoniazid sensitive
2 HRZE 4 HR
Rifampicin sensitive
LPA –isoniazid resistant
6 HRZE + Levofloxacin (full duration)
Rifampicin sensitive
LPA –isoniazid not done because of no
access to LPA
6 HRZE (full duration)
All patients with TB meningitis and TB pericarditis will also receive steroids in addition to TB t/t.
NTP no longer recommends category II which includes streptomycin to be used and officially
phased out category II regimen
8/13/2019 NISCHAL SHRESTHA 4
5. MDR-TB t/t Regimen
Kanamycin Km
Moxifloxacin / levofloxacin Mfx / Lfx
Ethionamide Eto
Clofazimine Cfz
Pyrazinimide Z
Ethambutol E
Cycloserine Cs
For t/t of MDR regimen, NTP has also initiated a shorter MDR t/t regimen as
well as conventional longer regimen.
8/13/2019 NISCHAL SHRESTHA 5
8. Kanamycin is not to be included in t/t of MDR/RR –TB patients
on longer regimens.
Bedaquiline (Bdq) is a new class drug specifically targeting
mycobacterial ATP synthetase. Is given for 6 months in pre-
XDR and XDR TB t/t regimen.
8/13/2019 NISCHAL SHRESTHA 8